Dr. Howard I Scher MD
Oncologist | Medical Oncology
1275 York Ave New York NY, 10021About
I am Chief of the Genitourinary Oncology Service at the Sidney Kimmel Center for Urologic and Prostate Cancers at Memorial Sloan Kettering and a board-certified medical oncologist with special expertise ...
Education and Training
New York Univ Sch of Med, New York Ny 1976
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Post-therapy serum prostate-specific antigen level and survival in patients with
- Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.
- Management of prostate cancer after prostatectomy: treating the patient, not the PSA.
- Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.
- Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.
- Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer.
- Rising PSAs after primary therapy: active or passive intervention.
- Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
- Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
- Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man--clinical trials at Memorial Sloan-Kettering Cancer Center.
- Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models.
- Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence.
- Clinical states in prostate cancer: toward a dynamic model of disease progression.
- Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
- The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.
Fellowships
- Memorial Sloan - Kettering Cancer Center
- Cornell Univ. Medical College
Dr. Howard I Scher MD's Practice location
Dr. Howard I Scher MD's reviews
Write ReviewPatient Experience with Dr. Scher
Recommended Articles
- Ovarian Cancer: Get the Facts
Ovarian cancer is one of the deadliest types of cancer that affects the female population. The disease is very painful and uncomfortable, which can spread to the nearest organs in a very short time. If the disease is discovered at the first (localized) stage, the patient will have a 5-year survival...
- Investigating Lumps in Your Breasts
If you have felt a new breast lump that is the same or increasing in size gradually, it is always wise to show this to your health care professional. They will then do a series of tests to investigate if you have a benign lump or breast cancer. Diagnosing and treating early will give you a better...
- This Compound in Foods Found to Limit Effectiveness of Ovarian Cancer Drug
Pitavastatin targets HMGCR in ovarian cancer, and it has shown to be capable of regressing Ovcar-4 tumor xenographs. However, recent studies have shown that if a diet includes geranylgeraniol, the effectiveness of pitavastatin may be limited or stopped.Treating ovarian cancerUnfortunately, it is...
- What Is a Skin Biopsy?
A skin biopsy is a medical procedure which involves taking a skin tissue sample, processing it, and then examining it under a powerful microscope. Different methods exist for performing this procedure depending on the location and size of the skin abnormality. Any part of your skin that shows some...
- Ovarian Cancer Survivor Dedicates Herself to Helping Others
July 11th, 2014 is a day LeToy Hannah will never forget. She had gone into surgery to remove a non-cancerous cyst on her ovary and came out with a stage 3C ovarian cancer diagnosis. Hannah was shocked; her mother had to make the call to do a complete hysterectomy to remove all visible cancer while...
- How to Sort Out Financial Challenges of Breast Cancer
When a woman faces breast cancer, she should only have to worry about one thing: recovery. But the cold hard truth is that many women must face the reality financial hardship during an already tumultuous time. The outcomes of bankruptcy, welfare, and losing the family home are not usually what we...
Nearby Providers
- Dr. Maria Theodoulou MD1275 York Ave New York NY 10021
- Dr. Richard Carvajal M.D.1275 York Ave New York NY 10021
- Dr. Mark Frattini MD1275 York Ave New York NY 10021
- Dr. Craig Moskowitz MD1275 York Ave New York NY 10021
- Dr. Andrew Zalenetz MD1275 York Ave New York NY 10021
- Dr. Emil Lou M.D., PH.D1275 York Avenue New York NY 10021